Table: Taiko Pharmaceutical -Q1 group results

Taiko Pharmaceutical

13/05/2022 07:30

May 13 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2022        Mar 31, 2021     Dec 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            621 mln              3.27                      
  Operating       loss 1.67         loss 190 mln                  
  Recurring       loss 1.74         loss 232 mln                  
  Net             loss 1.75         loss 147 mln                  
  EPS          loss 40.13 yen       loss 3.39 yen                 
  Ann Div                                NIL                      
  -Q2 div                                NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T